Our core strengths in medicinal chemistry and translational science enable us to discover and develop potentially differentiated, novel compounds against biologically or clinically validated targets.

Our team combines high skills in medicinal chemistry and translational science with deep-rooted biotech and experience, and has successfully generated numerous drug candidates to be progressed through discovery and into the clinic.

Our commitment is to bring hope to patients with fibrosis through the discovery and development of breakthrough therapies for fibrotic diseases.

Our candidates has now shown anti-fibrotic effects in a range of cellular and animal models and an encouraging safety and pharmacokinetic profile. This represents an important milestone in development of this novel drug.

We are honored to present our findings for fibrosis diseases community. We will very much appreciate the support we may have from the community and directions to reach anyone we can help affected from this debilitating disease.